Decorin promotes myogenic differentiation and mdx mice therapeutic effects after transplantation of rat adipose-derived stem cells

References

• Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta. 2007;1772:229–37.
   PubMed Web of Science ®Google Scholar
• Goudenege S, Pisani DF, Wdziekonski B, Di Santo JP, Bagnis C, Dani C, . Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.. Mol Ther. 2009;17:1064–72.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan X, Sun Z, Chen B, Han Q, Li J, . Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev. 2007;16:695–706.
   PubMed Web of Science ®Google Scholar
• Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne JY, Wdziekonski B, . Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med. 2005;201:1397–405.
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83–90.
   PubMed Web of Science ®Google Scholar
• Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, . Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab. 2003;285:E876–88.
   PubMed Web of Science ®Google Scholar
• Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, . Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology. 2005;146:3547–57.
   PubMed Web of Science ®Google Scholar
• Rios R, Carneiro I, Arce VM, Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol. 2002;282:C993–9.
   PubMed Web of Science ®Google Scholar
• Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem. 2002;277: 49831–40.
   PubMed Web of Science ®Google Scholar
• Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem. 1989;264: 4571–6.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Oyama K, Kishioka Y, Wakamatsu J, Hattori A. Spatiotemporal expression of decorin and myostatin during rat skeletal muscle development. Biochem Biophys Res Commun. 2007;361:896–902.
   Google Scholar
• Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, . Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem. 2007;282:25852–63.
   PubMed Web of Science ®Google Scholar
• Miura T, Kishioka Y, Wakamatsu J, Hattori A, Hennebry A, Berry CJ, . Decorin binds myostatin and modulates its activity to muscle cells. Biochem Biophys Res Commun. 2006;340:675–80.
   PubMedGoogle Scholar
• Kishioka Y, Thomas M, Wakamatsu J, Hattori A, Sharma M, Kambadur R, . Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity. J Cell Physiol. 2008;215:856–67.
   PubMed Web of Science ®Google Scholar
• Li Y, Li J, Zhu J, Sun B, Branca M, Tang Y, . Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther. 2007;15:1616–22.
   PubMed Web of Science ®Google Scholar
• Li X, McFarland DC, Velleman SG. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation. Decorin and transforming growth factor-beta1 in satellite cells. Domest Anim Endocrinol. 2008;35:263–73.
   Google Scholar
• Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18:1417–26.
   PubMed Web of Science ®Google Scholar
• Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol. 2003;23:7230–42.
   PubMed Web of Science ®Google Scholar
• Geng J, Peng F, Xiong F, Shang Y, Zhao C, Li W, . Inhibition of myostatin promotes myogenic differentiation of rat bone marrow-derived mesenchymal stromal cells. Cytotherapy. 2009;11:849–63.
   Web of Science ®Google Scholar
• Benabdallah BF, Bouchentouf M, Rousseau J, Bigey P, Michaud A, Chapdelaine P, . Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transplant. 2008;17:337–50.
   PubMed Web of Science ®Google Scholar
• Benabdallah BF, Bouchentouf M, Tremblay JP. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Transplantation. 2005;79:1696–702.
   Google Scholar
• Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, . Functional improvement of dystrophic muscle by myostatin blockade. Nature. 2002;420: 418–21.
   PubMed Web of Science ®Google Scholar
• Abe S, Hirose D, Kado S, Iwanuma O, Saka H, Yanagisawa N, . Increased expression of decorin during the regeneration stage of mdx mouse. Anat Sci Int. 2009;84: 305–11.
   Google Scholar
• Zanotti S, Saredi S, Ruggieri A, Fabbri M, Blasevich F, Romaggi S, . Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biol. 2007;26: 615–24.
   PubMed Web of Science ®Google Scholar